Filter
1351
Filtered Results: 1351
Text search:
East
Asia
and
the
Pacific
Featured
Recommendations
120
New Publications
313
Language
Document type
No document type
664
Studies & Reports
362
Guidelines
149
Manuals
63
Strategic & Response Plan
48
Fact sheets
16
Training Material
13
Situation Updates
13
Resource Platforms
11
Infographics
11
Online Courses
1
Countries / Regions
Global
125
South–East Asia Region
47
Myanmar / Burma
45
Asia
36
India
26
Philippines
24
Indonesia
21
Bangladesh
20
Nepal
18
Cambodia
18
Africa
17
Western Pacific Region
15
Western and Central Europe
14
Congo, Democratic Republic of
11
Syria
11
Thailand
11
Middle East and North Africa
11
Nigeria
9
Afghanistan
9
Ethiopia
8
Pakistan
8
Kenya
8
South Africa
8
Yemen
8
China
7
Latin America and the Carribbean
7
Russia
6
Sierra Leone
5
Rwanda
5
Mozambique
5
East and Southern Africa
5
Eastern Europe and Central Asia
5
Venezuela
5
Laos
5
Vietnam
5
Liberia
4
Ghana
4
South Sudan
4
Tanzania
4
Madagascar
4
Sri Lanka
4
West and Central Africa
4
Uganda
3
Somalia
3
Malawi
3
Papua New Guinea
3
Brazil
3
Eastern Europe
3
Cameroon
2
Niger
2
Zimbabwe
2
Malaysia
2
Central African Republic
2
Ukraine
2
Colombia
2
Palestine
2
Timor Leste/ East Timor
2
North America
2
Guinea
1
Burkina Faso
1
Guinea-Bissau
1
USA
1
Haiti
1
Iraq
1
Jordan
1
Lebanon
1
Zambia
1
Egypt
1
Singapore
1
Sudan
1
Benin
1
Vanuatu
1
Namibia
1
Peru
1
Eswatini/ Swaziland
1
North Macedonia
1
Serbia
1
Ecuador
1
Botswana
1
Angola
1
Mexico
1
Other region
1
Solomon Islands
1
North Korea
1
Armenia
1
Mongolia
1
Tajikistan
1
Moldova
1
Iran
1
Georgia
1
Japan
1
Belgium
1
Maldives
1
Spain
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
256
Clinical Guidelines
139
Women & Child Health
102
Public Health
93
Key Resources
72
Capacity Building
25
Pharmacy & Technologies
16
Annual Report MEDBOX
1
Toolboxes
HIV
164
Mental Health
140
COVID-19
117
Planetary Health
104
Disability
59
Rapid Response
53
Global Health Education
53
TB
49
NTDs
41
AMR
38
Natural Hazards
33
Caregiver
33
NCDs
32
Health Financing Toolbox
30
Refugee
28
Conflict
20
Zika
19
Pharmacy
17
Ebola
13
Polio
7
Specific Hazards
5
Cholera
3
Typhoon
3
Social Ethics
2
Health Financing
1
These guidelines present evidence-based recommendations and best practice statements on use of medically important antimicrobials in food-producing animals, based on the WHO list of critically impor...
The Global Burden of Disease (GBD) study, a collaborative endeavour of the World
Health Organization (WHO), the World Bank ... the Harvard School of Public Health,
drew the attention of the international health community to the burden of neurological
disorders and many other chronic conditions. This study found that the burden of neurological
disorders was seriously underestimated by traditional epidemiological and health
statistical methods that take into account only mortality rates but not disability rates. The
GBD study showed that over the years the global health impact of neurological disorders
had been underestimated.
This fourth annual report monitors global progress towards the 2023 target for global elimination of industrially produced trans-fatty acids (TFA), highlighting achievements during the past year (Oc...
The World Heart Federation (WHF) Roadmap series covers a large range of cardiovascular conditions. These Roadmaps identify potential roadblocks and their solutions to improve ... prevention, detection and management of cardiovascular diseases and provide a generic global framework available for local adaptation. A first Roadmap on raised blood pressure was published in 2015. Since then, advances in hypertension have included the publication of new clinical guidelines (AHA/ACC; ESC; ESH/ISH); the launch of the WHO Global HEARTS Initiative in 2016 and the associated Resolve to Save Lives (RTSL) initiative in 2017; the inclusion of single-pill combinations on the WHO Essential
Medicines’ list as well as various advances in technology, in particular telemedicine and mobile health. Given the substantial benefit accrued from effective interventions in the management of hypertension and their potential for scalability in low and middle-income countries (LMICs), the WHF has now revisited and updated the ‘Roadmap for raised BP’ as ‘Roadmap for hypertension’
by incorporating new developments in science and policy. Even though cost-effective lifestyle and medical interventions to prevent and manage hypertension exist, uptake is still low, particularly in resource-poor areas. This Roadmap examined the roadblocks pertaining to both the demand side (demographic and socio-economic factors, knowledge and beliefs, social relations, norms, and
traditions) and the supply side (health systems resources and processes) along the patient pathway to propose a range of possible solutions to overcoming them. Those include the development of population-wide prevention and control programmes; the implementation of opportunistic screening and of out-of-office blood pressure measurements; the strengthening of primary care and a greater focus on task sharing and team-based care; the delivery of people-centred care and stronger patient and carer education; and the facilitation of adherence to treatment. All of the above are dependent upon the availability and effective distribution of good quality, evidencebased, inexpensive BP-lowering agents.
The IDF Diabetes Atlas report highlights the disproportionate prevalence of type 2 diabetes (T2D) among Indigenous Peoples globally. It emphasizes the...
This fourth annual report monitors global progress towards the 2023 target for global elimination of industrially produced trans-fatty acids (TFA), highlighting achievements during the past year (Oc...
National action plans on antimicrobial resistance (AMR) often overlook the critical intersection of gender, despite evidence that exposure and susceptibility to infection, health-seeking behaviours,...
World Report 2021, Human Rights Watch’s 31st annual review of human rights practices and trends around the globe, reviews developments in more than 100 countries.
In his introductory essay, Exe...
This Teacher’s Guide accompanies the WHO publication Management of wastes from health-care activities . It provides teaching materials and recommendations for a three day training course, designed...
The country profiles incorporate facts indicating the national status of medical devices in areas such as: medical device policies, regulations, incorporation, lists, inventories, nomenclature, he...
The HEARTS technical package provides a strategic approach to improving cardiovascular health in countries. It comprises six modules and an implementation guide. This package supports Ministries of ...
WHO needs US$2.54 billion to provide life-saving assistance to millions of people around the world facing health emergencies. WHO’s Health Emergency Appeal is a consolidation of WHO’s priorities and...
The development of this draft Proposed programme budget 2022–2023 comes at a unique moment for WHO. The world is in the grip of ... coronavirus disease (COVID-19) pandemic and faces health, social and economic consequences on an unprecedented scale. Although it is not known when the COVID-19 pandemic will end, recent encouraging vaccine results, in addition to the examples of countries that have achieved good results through public health measures, hold out the prospect of better days ahead. The full impact of the pandemic cannot yet be determined. But whatever its implications, the Secretariat will rise to the challenge and is ready to adapt so that it is fully equipped to support Member States for any eventuality in the future – to make sure that the world will never again have to face this kind of crisis.
Webinar.
The purpose of this booklet is to help readers understand why data on children with disabilities are currently inadequate, the difficulties that surround ... gathering of high-quality data on disabled children, and why there is a real need to improve the collection, analysis, dissemination and use of disability data.
This manual is designed primarily to assist managers of national malaria programmes and national reference laboratory responsible for quality assurance of malaria microscopy control. The information...
mhGAP is based on evidence-based technical guidelines (4) and provides a set of tools and
training packages to extend service provision. The mhGAP...
At present at least 2.2 billion people around the world have a vision impairment, of whom at least 1 billion have a vision impairment that could have been prevented or is yet to be addressed. The wo...
In Control. A Practical Handbook for Professionals Working in Health Emergencies Internationally
recommended
In Control imparts knowledge, provokes reflection and triggers curiosity. The first half of the book provides an overview of ... organisations, principles, frameworks and themes that every professional deploying to health emergencies should be aware of. The second half of the book provides practical advice to help professionals survive and thrive during their mission – from staying healthy, protecting oneself from cyber-attacks and coping with stress to building trust among the host community or dealing with language barriers and the press.
This handbook is free of charge and can be made available in small quantities as long as supply lasts. To order, please send this form to: incontrol-handbook@rki.de
This document is an output of a WHO cross-programme initiative aiming to improve the prevention, diagnosis and management of anaemia and thereby ac...
Guideline ‒ Alternative mass drug administration regimens to eliminate lymphatic filariasis
recommended
Lymphatic filariasis is a vector-borne neglected tropical disease that causes damage of the lymphatic system and can lead to lymphoedema (elephantiasis) a... hydrocele in infected individuals. The global baseline estimate of persons affected by lymphatic filariasis is 25 million men with hydrocele and over 15 million people with lymphoedema. At least 36 million persons remain with these chronic disease manifestations. The disease is endemic in 72 countries. In 2016, an estimated total population of 856 million were living in areas with ongoing transmission of the causative filarial parasites and requiring mass drug administration (MDA). Lymphatic filariasis disfigures and disables, and often leads to stigmatization and poverty. Hundreds of millions of dollars are lost annually due to reduced productivity of affected patients. WHO has ranked the disease as one of the world’s leading causes of permanent and long-term disability.
